119 related articles for article (PubMed ID: 8525817)
1. Prevention of heterotopic ossification with tenoxicam following total hip arthroplasty: a double-blind, placebo-controlled dose-finding study.
Burssens A; Thiery J; Kohl P; Molderez A; Haazen L
Acta Orthop Belg; 1995; 61(3):205-11. PubMed ID: 8525817
[TBL] [Abstract][Full Text] [Related]
2. Heterotopic ossification after hip arthroplasty: a randomized double-blind multicenter study tenoxicam in 147 hips.
Gebuhr P; Sletgård J; Dalsgård J; Soelberg M; Keisu K; Hänninen A; Crawford M
Acta Orthop Scand; 1996 Feb; 67(1):29-32. PubMed ID: 8615097
[TBL] [Abstract][Full Text] [Related]
3. Double-blind comparison of the efficacy and safety of etodolac SR 600 mg u.i.d. and of tenoxicam 20 mg u.i.d. in elderly patients with osteoarthritis of the hip and of the knee.
Perpignano G; Bogliolo A; Puccetti L
Int J Clin Pharmacol Res; 1994; 14(5-6):203-16. PubMed ID: 7672877
[TBL] [Abstract][Full Text] [Related]
4. Nonsteroidal anti-inflammatory drugs for prevention of heterotopic ossification after total hip arthroplasty.
Nilsson OS
Semin Arthroplasty; 1992 Jul; 3(3):172-7. PubMed ID: 10147776
[TBL] [Abstract][Full Text] [Related]
5. The use of indomethacin to prevent the formation of heterotopic bone after total hip replacement. A randomized, double-blind clinical trial.
Schmidt SA; Kjaersgaard-Andersen P; Pedersen NW; Kristensen SS; Pedersen P; Nielsen JB
J Bone Joint Surg Am; 1988 Jul; 70(6):834-8. PubMed ID: 3134359
[TBL] [Abstract][Full Text] [Related]
6. Naproxen in the prevention of heterotopic ossification after total hip replacement.
Vielpeau C; Joubert JM; Hulet C
Clin Orthop Relat Res; 1999 Dec; (369):279-88. PubMed ID: 10611883
[TBL] [Abstract][Full Text] [Related]
7. Prevention of heterotopic ossification by nonsteroid antiinflammatory drugs after total hip arthroplasty.
Sodemann B; Persson PE; Nilsson OS
Clin Orthop Relat Res; 1988 Dec; (237):158-63. PubMed ID: 3142716
[TBL] [Abstract][Full Text] [Related]
8. [Eight days of naproxen therapy can prevent heterotopic ossification after total hip alloplasty].
Gebuhr PH; Wilbek H; Soelberg M
Ugeskr Laeger; 1996 Feb; 158(8):1076-8. PubMed ID: 8638341
[TBL] [Abstract][Full Text] [Related]
9. Ketorolac prophylaxis against heterotopic ossification after hip replacement.
Pritchett JW
Clin Orthop Relat Res; 1995 May; (314):162-5. PubMed ID: 7634630
[TBL] [Abstract][Full Text] [Related]
10. Indomethacin for prevention of heterotopic ossification. A randomized controlled study in 41 hip arthroplasties.
Kjaersgaard-Andersen P; Nafei A; Teichert G; Kristensen O; Schmidt SA; Keller J; Lucht U
Acta Orthop Scand; 1993 Dec; 64(6):639-42. PubMed ID: 8291408
[TBL] [Abstract][Full Text] [Related]
11. No effect of low-dose aspirin for the prevention of heterotopic bone formation after total hip replacement: a randomized trial of 2,649 patients.
Neal BC; Rodgers A; Gray H; Clark T; Beaumont DD; House T; Douglas JE; Reid IR; MacMahon SW
Acta Orthop Scand; 2000 Apr; 71(2):129-34. PubMed ID: 10852317
[TBL] [Abstract][Full Text] [Related]
12. Preventive effects of ibuprofen on periarticular heterotopic ossification after total hip arthroplasty. A randomized double-blind prospective study of treatment time.
Persson PE; Sodemann B; Nilsson OS
Acta Orthop Scand; 1998 Apr; 69(2):111-5. PubMed ID: 9602764
[TBL] [Abstract][Full Text] [Related]
13. Comparative double blind study of the efficacy and safety of tenoxicam vs. piroxicam in osteoarthritis of knee and hip joints.
Adelowo OO; Chukwuani CM; Grange JJ; Ojeasebhulo EE; Onabowale BO
West Afr J Med; 1998; 17(3):194-8. PubMed ID: 9814091
[TBL] [Abstract][Full Text] [Related]
14. Results of the administration of diphosphonate for the prevention of heterotopic ossification after total hip arthroplasty.
Thomas BJ; Amstutz HC
J Bone Joint Surg Am; 1985 Mar; 67(3):400-3. PubMed ID: 3919028
[TBL] [Abstract][Full Text] [Related]
15. Double-blind parallel study of tenoxicam (20 mg vs. 40 mg) in extra-articular inflammation.
Tuso L; Jeunet F; Kunovits G; Pasquier M
Eur J Rheumatol Inflamm; 1987; 9(2):129-32. PubMed ID: 3329105
[No Abstract] [Full Text] [Related]
16. No difference between two doses of diclofenac in prophylaxis of heterotopic ossifications after total hip arthroplasty.
Sell S; Phillips O; Handel M
Acta Orthop Scand; 2004 Feb; 75(1):45-9. PubMed ID: 15022805
[TBL] [Abstract][Full Text] [Related]
17. Prevention of heterotopic ossification with irradiation after total hip arthroplasty. Radiation therapy with a single dose of eight hundred centigray administered to a limited field.
Pellegrini VD; Konski AA; Gastel JA; Rubin P; Evarts CM
J Bone Joint Surg Am; 1992 Feb; 74(2):186-200. PubMed ID: 1541613
[TBL] [Abstract][Full Text] [Related]
18. A double-blind comparison of tenoxicam (Tilcotil, Mobiflex) at two doses against ibuprofen in rheumatoid arthritis.
Bird HA; Hill J; Lowe JR; Wright V
Eur J Rheumatol Inflamm; 1984; 7(2):28-32. PubMed ID: 6400518
[TBL] [Abstract][Full Text] [Related]
19. [Clinical study on the prevention of heterotopic ossification after total hip arthroplasty by Xiaozhong Zhitong].
Liu HP; Li YJ; Wang CX; Li SH; Zhao ZW; Wang JH
Zhongguo Gu Shang; 2011 Oct; 24(10):857-60. PubMed ID: 22097138
[TBL] [Abstract][Full Text] [Related]
20. Diacerhein in the treatment of osteoarthritis of the hip.
Nguyen M; Dougados M; Berdah L; Amor B
Arthritis Rheum; 1994 Apr; 37(4):529-36. PubMed ID: 8147930
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
